Results 11 to 20 of about 2,246 (191)

Clinical significance of gastrointestinal bleeding history in patients who undergo left atrial appendage closure [PDF]

JGH Open, 2023
Background and Aim: Anticoagulant users with nonvalvular atrial fibrillation (NVAF) sometimes suffer from gastrointestinal bleeding (GIB) and have difficulty continuing the medication.
Inoo, Shoko, Okada, Hiroyuki, Hamada, Kenta, Kuraoka, Sakiko, Takaya, Yoichi, Kawano, Seiji, Satomi, Takuya, Iwamuro, Masaya, Hirata, Shoichiro, Kawahara, Yoshiro, Okanoue, Shotaro, Kono, Yoshiyasu, Nakagawa, Koji, Miyamoto, Masakazu, Kikuchi, Tatsuya, Matsueda, Katsunori   +15 more
core   +3 more sources

Antithrombotic Therapy after Percutaneous Left Atrial Appendage Closure: Evidence, Challenges and Future Directions. [PDF]

Reviews in Cardiovascular Medicine, 2023
Percutaneous left atrial appendage closure (LAAC) has been established in clinical practice as an attractive alternative to oral anticoagulation for preventing stroke in patients with atrial fibrillation and high bleeding risk.
Galea, Roberto, Räber, Lorenz
core   +5 more sources

The Future of LAAC—In 5, 10, and 20 Years

Interventional Cardiology Clinics, 2022
Early experience with percutaneous LAA closure documented complication rates of ∼10%, with failure to implant devices in ∼10% of patients. These numbers are unrecognizable in contemporary practice due to the iterative changes made largely in the last 10 years.
Daniels, Matthew J, Parry-Jones, Adrian; id_orcid 0000-0002-4462-3846   +1 more
core   +7 more sources

Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta‐Analysis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Percutaneous left atrial appendage closure (LAAC) has been suggested as an alternative to long‐term oral anticoagulation for nonvalvular atrial fibrillation, but comparative data remain scarce. We aimed to assess ischemic and bleeding outcomes
Angelo Oliva, Giuseppe Ferrante, Bernhard Reimers, Alessia Azzano, Giulio Stefanini, Anna Maria Ioppolo, Gianluigi Condorelli, Mauro Chiarito, Philippe Garot, Alberto Cremonesi, Davide Cao, Eligio Miccichè, Francesco Ariano, Roxana Mehran, Andrea Mangiameli, Nicolas Amabile   +15 more
core   +2 more sources

Safety and feasibility of atrial fibrillation ablation after left atrial appendage closure: A single‐center experience of the left atrial appendage closure first strategy

Journal of Arrhythmia
Background Patients with atrial fibrillation (AF) who are not suitable for long‐term anticoagulant therapy undergo percutaneous left atrial appendage closure (LAAC).
Shunsuke Kubo, Ryuki Chatani, Atsushi Sakata, Kazushige Kadota, Hiroshi Tasaka, Mitsuru Yoshino, Takeshi Maruo   +6 more
core   +2 more sources

Combined Therapy of Catheter Ablation and Left Atrial Appendage Closure for Patients with Atrial Fibrillation: A Case-Control Study

Journal of Interventional Cardiology, 2020
Aim. The feasibility and safety of performing the combined procedure of catheter ablation (CA) and left atrial appendage closure (LAAC) for atrial fibrillation (AF) have been reported by observational studies without controls.
Peng-Pai Zhang, Jia-Li Yuan, Jian Sun, Yi-Gang Li, Qun-Shan Wang, Wei Li, Bin-Feng Mo, Yi Yu, Mu Chen   +8 more
core   +2 more sources

Association Between Insulin Resistance and Incomplete Endothelization of LAAC Devices in Patients with Atrial Fibrillation: A Retrospective Study

Cardiology and Therapy
Incomplete endothelialization (IDE) of left atrial appendage closure (LAAC) devices increases the risk of device-related thrombosis (DRT) and stroke. Insulin resistance (IR) may contribute to IDE by impairing endothelial function, but its role remains unclear.
Jing Zhou, En Zhou, Qing He, Kandi Zhang, Tiantian Zhang, Chengyu Mao, Junfeng Zhang, Zongqi Zhang   +7 more
openaire   +4 more sources

Efficacy and safety of concomitant left atrial appendage closure and pulmonary vein isolation compared to left atrial appendage closure only - A meta-analysis. [PDF]

Int J Cardiol Heart Vasc
Background: Atrial fibrillation (AF) is associated with an increased risk of ischemic stroke, primarily originating from the left atrial appendage (LAA).
Rattka I, Poch C, Mews T, Friesacher C, Jurik N, Martens E, Laugwitz KL, Steger A, Rattka M.   +8 more
europepmc   +2 more sources

Left Atrial Appendage Closure vs. Oral Anticoagulation in Patients With Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

J Arrhythm
Efficacy and safety outcomes from meta‐analysis of left atrial appendage closure versus anticoagulation therapy in atrial fibrillation. Pooled analysis of 3116 participants from four randomized trials demonstrated comparable composite outcome of stroke, systemic embolism, and cardiovascular/unexplained mortality between LAAC and standard ...
Chilaka C, Khan HD, Sarfraz MU, Farooq Z, Hassan E, Sabir R, Siddique S, Zahid N, Rehman MU, Salih M, Umer M, Alsubari AMA, Ehsan M.   +12 more
europepmc   +2 more sources

Different Techniques of Surgical Left Atrial Appendage Closure and Their Efficacy: A Systematic Review

Reviews in Cardiovascular Medicine, 2023
Background: Atrial fibrillation has been identified as an independent risk factor for thromboembolic events. Since 1948 different surgical techniques have described the feasibility and the rationale of left atrial surgical appendage closure.
Mizar D'Abramo, Silvia Romiti, Sara Saltarocchi, Wael Saade, Flaminia Spunticchia, Noemi Bruno, Mariangela Peruzzi, Fabio Miraldi, Giacomo Frati, Ernesto Greco, Francesco Macrina, Paolo De Orchi, Antonino G. M. Marullo   +12 more
doaj   +1 more source